Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,204 results
- Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01719744).
- Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01942837).
- Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT): Complete Statistical AnalysisIndependent statistical analysis of Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Everolimus (RAD001) in Combination With Lenalidomide: Complete Statistical AnalysisIndependent statistical analysis of Study of Everolimus (RAD001) in Combination With Lenalidomide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01218555).
- Study of EXPAREL in Patients Undergoing Breast Augmentation: Complete Statistical AnalysisIndependent statistical analysis of Study of EXPAREL in Patients Undergoing Breast Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01582490).
- Study of Fampridine-SR Tablets in Multiple Sclerosis Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Fampridine-SR Tablets in Multiple Sclerosis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00483652).
- Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL): Complete Statistical AnalysisIndependent statistical analysis of Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration: Complete Statistical AnalysisIndependent statistical analysis of Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00187135).
- Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Gardasil in Mid-Adult Males (MAM): Complete Statistical AnalysisIndependent statistical analysis of Study of Gardasil in Mid-Adult Males (MAM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01432574).
- Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.: Complete Statistical AnalysisIndependent statistical analysis of Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Glycopyrronium in Axillary Hyperhydrosis: Complete Statistical AnalysisIndependent statistical analysis of Study of Glycopyrronium in Axillary Hyperhydrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02530281).
- Study of GSK2586881 on Acute Hypoxia and Exercise: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK2586881 on Acute Hypoxia and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03000686).
- Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer: primary endpoint results, effect estimate…
- Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B: Complete Statistical AnalysisIndependent statistical analysis of Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib: Complete Statistical AnalysisIndependent statistical analysis of Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA): Complete Statistical AnalysisIndependent statistical analysis of Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00831623).
- Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD: Complete Statistical AnalysisIndependent statistical analysis of Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma: primary endpoint results, effect estimate with…
- Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Intraoperative Radiotherapy for Patients With Large Brain Metastases Treated With Neurosurgical Resection: Complete Statistical AnalysisIndependent statistical analysis of Study of Intraoperative Radiotherapy for Patients With Large Brain Metastases Treated With Neurosurgical Resection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen: Complete Statistical AnalysisIndependent statistical analysis of Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00911495).
- Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV: Complete Statistical AnalysisIndependent statistical analysis of Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers: Complete Statistical AnalysisIndependent statistical analysis of Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers: Complete Statistical AnalysisIndependent statistical analysis of Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC): Complete Statistical AnalysisIndependent statistical analysis of Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty: Complete Statistical AnalysisIndependent statistical analysis of Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Lunesta Versus Placebo for Sleep Problems Related to Smoking Cessation and Zyban: Complete Statistical AnalysisIndependent statistical analysis of Study of Lunesta Versus Placebo for Sleep Problems Related to Smoking Cessation and Zyban: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of LY3039478 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Study of LY3039478 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02906618).
- Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring: Complete Statistical AnalysisIndependent statistical analysis of Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring: primary endpoint results, effect estimate…
- Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Metoclopramide in Small Bowel Capsule Endoscopy: Complete Statistical AnalysisIndependent statistical analysis of Study of Metoclopramide in Small Bowel Capsule Endoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01630109).
- Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epilepticus (Convulsive) in the Community Setting: Complete Statistical AnalysisIndependent statistical analysis of Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epilepticus (Convulsive) in the Community Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors (Cohorts A, B and C): Complete Statistical AnalysisIndependent statistical analysis of Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors (Cohorts A, B and C): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of MLN8237 in Participants With Advanced Hematological Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Study of MLN8237 in Participants With Advanced Hematological Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00697346).
- Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212): Complete Statistical AnalysisIndependent statistical analysis of Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212): primary endpoint results, effect estimate with confidence interval, sample-size planning…